Glucose Exposure: Incremental vs. Full-dose PD

A 2-year retrospective study of 117 patients (46 incremental; 71 full-dose) with a 12 or more months of PD and 24-hour urine volume > 500 mL analyzed Q6-month cardiometabolic parameter trends: dry weight, BMI, HbA1c, cholesterol, serum glucose. HbA1c—lower in incremental PD users—was the only significant baseline difference between groups. The incremental group had significantly less estimated cumulative glucose exposure.

Read the abstract » | (added 2025-05-20)

Tags: Glucose Exposure, Incremental, Full dose PD, Cardiometabolic Parameter Trends